Real-time enrollment status for this internuclear ophthalmoplegia clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 4:47 PM UTC
| NCT Number | NCT06417216 |
| Recruiting Status | Recruiting |
| Condition | Internuclear Ophthalmoplegia |
| Phase | NA |
| Target Enrollment | 40 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Kevin Houston |
| Last Updated on CT.gov | April 6, 2026 (Apr 6, 2026) |
As of September 1, 2026: Clinical trial NCT06417216 is currently recruiting participants. This na study for internuclear ophthalmoplegia is actively seeking new participants at 2 locations across the United States. The study is sponsored by Kevin Houston. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06417216 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06417216 was last updated Apr 6, 2026 (April 6, 2026). HelloStudys verifies this status automatically.